Gene therapy in cutaneous wound healing

Frontiers in Bioscience

Volumn 12, Issue 7, 2007, Pages 2507-2518

  Hirsch, Tobias ^a   Spielmann, Malte ^a   Yao, Feng ^a   Eriksson, Elof ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenoviral vector; Antimicrobial peptides; Ballistic gene transfer; CTGF; Cutaneous wounds; EGF; Electroporation; FGF; Gene gun; Gene therapy; Gene transfer; Gene vector; Growth factors; Herpes simplex viral vector; HGF; Host defense peptides; HSV; IGF 1; KGF; Lentiviral vector; Lipoplex; Liposomes; Microseeding; PDGF BB; Retroviral vector; Retrovirus; Review; SiRNA; Skin injury; TGF beta; VEGF; Viral vector; Wound healing; Wounds

Indexed keywords

ADENOVIRIDAE; HERPES; LENTIVIRUS; SIMPLEXVIRUS;

TRANSCRIPTION FACTOR;

ANIMAL; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; INJURY; METABOLISM; METHODOLOGY; REVIEW; SKIN; VIRUS; WOUND HEALING;

ANIMALS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; SKIN; SKIN PHYSIOLOGY; TRANSCRIPTION FACTORS; VIRUSES; WOUND HEALING;

EID: 36048996840     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2251     Document Type: Review

References (145)

1. Mostow, E. N: Diagnosis and classification of chronic wounds. Clin Dermatol 12, 3-9 (1994) (Pubitemid 24050732)
2. American Diabetes Association (ADA): Complications of Diabetes in the United States. www.diabetes.org/diabetesstatistics/complications.jsp (2006)
3. Rees, R. H: Wound care centers: Costs, care, and strategies. Ad Skin & Wound Care. 6, 283-292 (1999)
4. Lynch S. E, J. C. Nixon, R. B Colvin, and H. N. Antoniades: Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci U S A 84, 7696-7700 (1987)
5. Steinstraesser L, M. Fohn, R. D. Klein, A. Aminlari, D. G. Remick, G. L. Su and S. C. Wang: Feasibility of biolistic gene therapy in burns. Shock 15, 272-277 (2001) (Pubitemid 33596718)
6. Yao, F and E. Eriksson: Gene therapy in wound repair and regeneration. Wound Rep Regen. 8, 443-451 (2000) (Pubitemid 32141448)
7. Makinen, K, H. Manninen, M. Hedman, P. Matsi, H. Mussalo, E. Alhava and S. Yla-Herttuala: Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 6, 127-133 (2002) (Pubitemid 36124280)
8. Margolis D. J, T. Crombleholme and M. Herlyn: Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV. PDGF-B for the treatment of a diabetic insensate foot ulcer. Wound Repair Regen 8, 480-493 (2000) (Pubitemid 32141452)
9. Christensen R, U. B. Jensen and T. G. Jensen: Cutaneous gene therapy-an update. Histochem Cell Biol 115, 73-82 (2001)
10. Steinstraesser L, B. F. Tack, A. J. Waring, T. Hong, L. M. Boo, M. H. Fan, D. I. Remick, G. L. Su, R. I. Lehrer, and S. C. Wang: Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother 46, 1837-1844 (2002) (Pubitemid 34535205)
11. Boucher R. C: Status of gene therapy for cystic fibrosis lung disease. J. Clin. Invest. 103, 441-445 (1999) (Pubitemid 29094042)
12. Andrews J. L, M. J. Kadan, M. I. Gorziglia, M. Kaleko, and S. Connelly: Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII. Mol Ther 3, 329-336 (2001) (Pubitemid 32514649)
13. Cavazzana-Calvo M, S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J. L. Casanova, P. Bousso, F. L. Deist, and A. Fischer: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672 (2000) (Pubitemid 30241569)
14. Morgan J. R, Y. Barrandon, H. Green, and R. C. Mulligan: Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237, 1476-1479 (1987) (Pubitemid 17125441)
15. Chesnoy S and L. Huang: Enhanced cutaneous gene delivery following intradermal injection of naked DNA in a high ionic strength solution. Mol Ther 5, 57-62 (2002) (Pubitemid 34110481)
16. Khavari P. A: Therapeutic gene delivery to the skin. Mol Med Today 3, 533-538 (1997) (Pubitemid 28022792)
17. Khavari P. A, and G. Krueger: Cutaneous gene therapy. Dermatol Clin 15, 27-35 (1997) (Pubitemid 27034652)
18. Khavari P. A, O. Rollman, and A. Vahlquist: Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252, 1-10 (2002) (Pubitemid 34743904)
19. Rowe W. P, R. J. Huebner, L. K. Gilmore, R. H. Parrott, T. G. Ward: Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exper. Biol. & Med. 84, 570-573 (1953)
20. Niemann T. H, M. E. Trigg, N. Winick, and G. D. Penick: Disseminated adenoviral infection presenting as acute pancreatitis. Hum Pathol 24, 1145-1148 (1993) (Pubitemid 23306250)
21. Ohori N. P, M. G. Michaels, R. Jaffe, P. Williams, and S. A. Yousem: Adenovirus pneumonia in lung transplant recipients. Hum Pathol 26, 1073-1079 (1995)
22. Horwitz M. S: Adenoviruses. In: Fields Virology. Eds: Fields, B. N, Knipe D. M, Raven Publishers, Philadelphia (1996)
23. Horwitz M. S: Adenoviruses, In: Fields Virology. Eds: Fields, B. N, Knipe D. M, Raven Publishers, Philadelphia (2001)
24. Salyapongse A. N, T. R. Billiar, and H. Edington: Gene therapy and tissue engineering. Clin Plast Surg 26, 663-676, (1999) (Pubitemid 29494167)
25. Horwitz, M. S: Adenoviridae and their replication In: Fields Virology. Eds: Fields, B. N, Knipe D. M, Raven Publishers, Philadelphia (1990)
26. Bergelson J. M, J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell and R. W. Finberg: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323 (1997) (Pubitemid 27114163)
27. Bergelson, J. M, A. Krithivas, L. Celi, G. Droguett, M. S. Horwitz, T. Wickham, R. L. Crowell and R. W. Finberg: The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. Journal of Virology 72, 415-419 (1998) (Pubitemid 28048853)
28. Greber, U. F, M. Willetts, P. Webster, and A. Helenius: Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75, 477-486 (1993) (Pubitemid 23335073)
29. Jones N, and T. Shenk: Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17, 683-689 (1979) (Pubitemid 9242344)
30. Nelson, J. E., and M. A. Kay: Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J Virol 71, 8902-8907 (1997) (Pubitemid 27446480)
31. Bett, A. J, W. Haddara, L. Prevec, and F. L. Graham: An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A 91, 8802-8806 (1994)
32. Goldsmith K. T, L. D. Dion, D. T. Curiel, and R. L. Garver: Trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus. Virology 248, 406-419 (1998) (Pubitemid 28417726)
33. Steinwaerder D. S, C. A. Carlson, and A. Lieber: Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats. J Virol 73, 9303-9313 (1999) (Pubitemid 29487086)
34. Tollefson A. E, T. W. Hermiston, D. L. Lichtenstein, C. F. Colle, R. A. Tripp, T. Dimitrov, K. Toth, C. E. Wells, P. C. Doherty, and W. S. Wold: Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392, 726-730 (1998) (Pubitemid 28207795)
35. Lai C. M, Y. K. Lai, and P. E. Rakoczy: Adenovirus and adeno-associated virus vectors. DNA Cell Biol 21, 895-913 (2002) (Pubitemid 36126695)
36. Yang Y, and J. M. Wilson: Clearance of adenovirusinfected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol 155, 2564-2570 (1995)
37. Schaack, J: Adenovirus vectors deleted for genes essential for viral DNA replication. Front Biosci 10, 1146-1155 (2005)
38. Wang Q, and M. H. Finer: Second-generation adenovirus vectors. Nat Med 2, 714-716 (1996) (Pubitemid 126664317)
39. Amalfitano A, M. A. Hauser, H. Hu, D. Serra, C. R. Begy and J. S. Chamberlain: Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J Virol 72, 926-933 (1998) (Pubitemid 28116869)
40. Mitani K, F. Graham, C. Caskey, and S. Kochanek: Rescue, Propagation, and Partial Purification of a Helper Virus-Dependent Adenovirus Vector. Proc Natl Acad Sci USA 92, 3854-3858 (1995)
41. Kochanek S: High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum Gene Ther 10, 2451-2459 (1999) (Pubitemid 29489720)
42. Fisher K. J, H. Choi, J. Burda, S. J. Chen, and J. M. Wilson: Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217, 11-22 (1996) (Pubitemid 26104727)
43. Kochanek S, P. R. Clemens, K. Mitani, H. H. Chen, S. Chan, and C. T. Caskey: A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci U S A 93, 5731-5736 (1996)
44. Nasz I. and E. Adam: Recombinant adenovirus vectors for gene therapy and clinical trials. Acta Microbiol Immunol Hung 48, 323-348 (2001) (Pubitemid 33660773)
45. Setoguchi Y, H. A. Jaffe, C. Danel, and R. G. Crystal: Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J Invest Dermatol 102, 415-421 (1994) (Pubitemid 24117178)
46. Lotze M. T, and T. A. Kost: Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther 9, 692-699 (2002) (Pubitemid 34847578)
47. Mitani K, and S. Kubo: Adenovirus as an integrating vector. Curr Gene Ther 2, 135-144 (2002)
48. Campbell C, S. Hultman, B. Cairns, S. DeSerres, and A. Meyer: Green fluorescent protein-adenoviral construct as a model for transient gene therapy for human cultured keratinocytes in an athymic mouse model. The Journal of Trauma 54, 72-79; discussion 79-80 (2003)
49. Ritter T, M. Lehmann, and H. D. Volk: Improvements in gene therapy: averting the immune response to adenoviral vectors. BioDrugs 16, 3-10 (2002) (Pubitemid 34303963)
50. Yang Y, Q. Li, H. Ertl and J. Wilson: Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015 (1995)
51. Michou A. I, L. Santoro, M. Christ, V. Julliard, A. Pavirani, and M. Mehtali: Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther 4, 473-482 (1997) (Pubitemid 27226591)
52. Sylvester K. G, M. Nesbit, A. Radu, M. Herlyn, N. S. Adzick and T. M. Crombleholme: Adenoviral-mediated gene transfer in wound healing: acute inflammatory response in human skin in the SCID mouse model. Wound Repair Regen 8, 36-44 (2000) (Pubitemid 30140798)
53. Vranckx J. J, F. Yao, N. Petrie, H. Augustinova, D. Hoeller, S. Visovatti, J. Slama, and E. Eriksson: In vivo gene delivery of Ad-VEGF121 to full-thickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing. Wound Repair Regen 13, 51-60 (2005) (Pubitemid 40250429)
54. Crystal R. G, B. G. Harvey, J. P. Wisnivesky, K. A. O'Donoghue, K. W. Chu, J. Maroni, J. C. Muscat, A. L. Pippo, C. E. Wright, R. J. Kaner, P. L. Leopold, P. D. Kessler, H. S. Rasmussen, T. K. Rosengart, and C. Hollmann: Analysis of risk factors for local delivery of low-and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther 13, 65-100 (2002) (Pubitemid 34075173)
55. Crombleholme, T. M: Adenoviral-mediated gene transfer in wound healing. Wound Repair Regen 8, 460-472 (2000) (Pubitemid 32141450)
56. Slama, J, C. Andree, T. Winkler, W. F. Swain, and E. Eriksson, E: Gene transfer. Ann Plast Surg 35, 429-439 (1995)
57. Gene Therapy Clinical Trials Worldwide. http://wiley.co.uk/wileychi/ genmed/clinincal/ (2006)
58. Jacobsen, F, D. Mittler, T. Hirsch, A. Gerhards, M. Lehnhardt, B. Voss, B, H. U. Steinau and L. Steinstraesser: Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther 12, 1494-1502 (2005) (Pubitemid 41508674)
59. Jacobsen F, A. Baraniskin, J. Mertens, D. Mittler, A. Mohammadi-Tabrisi, S. Schubert, M. Soltau, M. Lehnhardt, B. Behnke, S. Gatermann, H. U. Steinau, and L. Steinstraesser: Activity of histone H1.2 in infected burn wounds. J Antimicrob Chemother 55, 735-741 (2005) (Pubitemid 40691854)
60. Luo J. D, Y. Y. Wang, W. L. Fu, J. Wu, and A. F. Chen: Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation 110, 2484-2493 (2004) (Pubitemid 39407357)
61. Liechty K. W, M. Nesbit, M. Herlyn, A. Radu, N. S. Adzick, and T. M. Crombleholme: Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic impaired wound healing. J Invest Dermatol 113, 375-383 (1999) (Pubitemid 29449077)
62. Margolis D. J, T. Cromblehome, M. Herlyn, P. Cross, L. Weinberg, J. Filip and K. Propert: Clinical protocol. Phase I trial to evaluate the safety of H5.020CMV. PDGF-b and limb compression bandage for the treatment of venous leg ulcer: trial A. Hum Gene Ther 15, 1003-1019 (2004) (Pubitemid 39372577)
63. Buning, H, M. Braun-Falco and M. Hallek: Progress in the use of adeno-associated viral vectors for gene therapy. Cells Tissues Organs 177, 139-150 (2004) (Pubitemid 39294708)
64. Dutheil N, F. Shi, T. Dupressoir, and R. M Linden: Adeno-associated virus site-specifically integrates into a muscle-specific DNA region. Proc Natl Acad Sci U S A 97, 4862-4866 (2000) (Pubitemid 30238648)
65. Carter P. J and R. J. Samulski: Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 6, 17-27 (2000)
66. Chirmule N, K. Propert, S. Magosin, Y. Qian, R. Qian, and J. Wilson: Immune responses to adenovirus and adenoassociated virus in humans. Gene Ther 6, 1574-1583 (1999) (Pubitemid 29465516)
67. Donahue B. A, J. G. McArthur, S. K. Spratt, D. Bohl, C. Lagarde, L. Sanchez, B. A. Kaspar, B. A. Sloan, Y. L. Lee, O. Danos and R. O. Snyder: Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med 1, 31-42 (1999) (Pubitemid 129631061)
68. Grimm D, M. A. Kay and J. A. Kleinschmidt: Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 7, 839-850 (2003) (Pubitemid 36790261)
69. Braun-Falco M, A. Doenecke, H. Smola and M. Hallek: Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors. Gene Ther 6, 432-441 (1999) (Pubitemid 29132345)
70. Hengge U. R, and A. Mirmohammadsadegh: Adenoassociated virus expresses transgenes in hair follicles and epidermis. Mol Ther 2, 188-194 (2000)
71. Deodato B, N. Arsic, L. Zentilin, M. Galeano, D. Santoro, V. Torre, D. Altavilla, D. Valdembri, F. Bussolino, F. Squadrito, and M. Giacca: Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther 9, 777-785 (2002) (Pubitemid 34679305)
72. Galeano M, B. Deodato, D. Altavilla, D. Cucinotta, N. Arsic, H. Marini, V. Torre, M. Giacca, and F. Squadrito: Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 46, 546-555 (2003) (Pubitemid 36577800)
73. McCarty D. M, P. E. Monahan and R. J. SamulskiSelfcomplementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 8, 1248-1254: (2001) (Pubitemid 32780813)
74. Sun L, J. Li and X. Xiao: Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat Med 6, 599-602 (2000) (Pubitemid 30305914)
75. Eming S. A, J. R. Morgan and A. Berger: Gene therapy for tissue repair: approaches and prospects. Br J Plast Surg 50, 491-500 (1997) (Pubitemid 27470192)
76. Hacein-Bey-Abina S, C. von Kalle, M. Schmidt, F. Le Deist, N. Wulffraat, E. McIntyre, I. Radford, J. L. Villeval, C. C. Fraser, M. Cavazzana-Calvo and A. Fischer: A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348, 255-256 (2003) (Pubitemid 36077924)
77. Kiem H. P, S. Sellers, B. Thomasson, J. C. Morris, J. F. Tisdale, P. A. Horn, P. Hematti, R. Adler, K. Kuramoto, B. Calmels, A. Bonifacino, J. Hu, C. von Kalle, M. Schmidt, B. Sorrentino, A. Nienhuis, C. A. Blau, R. G. Andrews, R. E. Donahue, and C. E. Dunbar: Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemia. Mol Ther 9, 389-395 (2004) (Pubitemid 38404527)
78. Dolnikov A, S. Wotherspoon, M. Millington and G. Symonds: Retrovirus vector production and transduction: modulation by the cell cycle. J Gen Virol 84, 3131-3141 (2003) (Pubitemid 37336798)
79. Sinn P. L, S. L. Sauter, and P. B. McCray Jr: Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors-design, biosafety, and production. Gene Ther 12, 1089-1098 (2005) (Pubitemid 41030614)
80. Yi, Y, S. H. Hahm and K. H. Lee: Retroviral gene therapy: safety issues and possible solutions. Curr Gene Ther 5, 25-35 (2005) (Pubitemid 40246740)
81. Mulligan, R: The basic science of gene therapy. Science 260, 926-932 C (1993)
82. Yamashita M, and M. Emerman: Retroviral infection of non-dividing cells: old and new perspectives. Virology 344, 88-93 (2006) (Pubitemid 41814454)
83. Thomas C. E, A. Ehrhardt and M. A. Kay: Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4, 346-358 (2003) (Pubitemid 36538359)
84. Zufferey R, T. Dull, R. J. Mandel, A. Bukovsky, D. Quiroz, L. Naldini, and D. Trono: Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72, 9873-9880 (1998) (Pubitemid 28520853)
85. Indraccolo S, W. Habeler V. Tisato, L. Stievano, E. Piovan, V. Tosello, G. Esposito, R. Wagner, K. Uberla, L. Chieco-Bianchi, and A. Amadori: Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Cancer Res 62, 6099-6107 (2002) (Pubitemid 35244458)
86. Kordower J. H, M. E. Emborg, J. Bloch, S. Y. Ma, Y. Chu, L. Leventhal, J. McBride, E. Y. Chen, S. Palfi, B. Z. Roitberg, W. D. Brown, J. E. Holden, R. Pyzalski, M. D. Taylor, P. Carvey, Z. Ling, D. Trono, P. Hantraye, N. Deglon and P. Aebischer: Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767-773 (2000)
87. Ghazizadeh S, R. Harrington and L. Taichman: In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy. Gene Ther 6, 1267-1275 (1999) (Pubitemid 29359020)
88. Escamez M. J, M. Garcia, F. Larcher, A. Meana, E. Munoz, J. L. Jorcano and M. Del Rio: An in vivo model of wound healing in genetically modified skin-humanized mice. J Invest Dermatol 123, 1182-1191 (2004) (Pubitemid 39586844)
89. Lee J. A, J. A. Conejero, J. M. Mason, B. M. Parrett, K. D. Wear-Maggitti, R. T. Grant and A. S. Breitbart: Lentiviral transfection with the PDGF-B gene improves diabetic wound healing. Plast Reconstr Surg 116, 532-538 (2005) (Pubitemid 41077209)
90. Cavazzana-Calvo M, S. Hacein-Bey, G. de Saint Basile, F. Gross, E. Yvon, P. Nusbaum, F. Selz, C. Hue, S. Certain, J. L. Casanova, P. Bousso, F. L. Deist and A. Fischer: Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672, (2000) (Pubitemid 30241569)
91. Yao F, C. Theopold, D. Hoeller, O. Bleiziffer, and Z. Lu: Highly Efficient Regulation of Gene Expression by Tetracycline in a Replication-Defective Herpes Simplex Viral Vector. Mol Ther (2006)
92. Hasson E, Y. Slovatizky, Y. Shimoni, H. Falk, A. Panet and E. Mitrani: Solid tissues can be manipulated ex vivo and used as vehicles for gene therapy. J Gene Med 7, 926-935 (2005) (Pubitemid 41015541)
93. Yao F, T. Svensjo, T. Winkler, M. Lu, C. Eriksson and E. Eriksson: Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells. Hum Gene Ther 9, 1939-1950 (1998) (Pubitemid 28439099)
94. Epstein A. L, P. Marconi, R. Argnani and R. Manservigi: HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy. Curr Gene Ther 5, 445-458 (2005) (Pubitemid 41448350)
95. Yao F and E. Eriksson: A novel anti-herpes simplex virus type 1-specific herpes simplex virus type 1 recombinant. Human Gene Therapy 10, 1811-1818 (1999) (Pubitemid 29357687)
96. Chattopadhyay M, D. Krisky, D. Wolfe, J. C. Glorioso, M. Mata and D. J. Fink: HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther 12, 1377-1384 (2005) (Pubitemid 43090387)
97. Goss J. R, W. F. Goins, D. Lacomis, M. Mata, J. C. Glorioso and D. J. Fink: Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 51, 2227-2232 (2002) (Pubitemid 34729029)
98. Cotten M and E. Wagner: Non-viral approaches to gene therapy. Curr Opin Biotechnol 4, 705-710 (1993) (Pubitemid 24001486)
99. de Lima M. C, S. Simoes, P. Pires, R. Gaspar, V. Slepushkin and N. Duzgunes: Gene delivery mediated by cationic liposomes: from biophysical aspects to enhancement of transfection. Mol Membr Biol 16, 103-109 (1999) (Pubitemid 29179344)
100. Dass C. R: Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection. J Mol Med 82, 579-591 (2004) (Pubitemid 39312663)
101. Sun L, L. Xu, H. Chang, F. A. Henry, R. M. Miller, J. M. Harmon and T. B. Nielsen: Transfection with aFGF cDNA improves wound healing. J Invest Dermatol 108, 313-318 (1997) (Pubitemid 27116230)
102. Jeschke M. G, R. E. Barrow, H. K. Hawkins, M. T. Chrysopoulo, J. R Perez-Polo and D. N. Herndon: Effect of multiple gene transfers of insulinlike growth factor I complementary DNA gene constructs in rats after thermal injury. Arch Surg 134, 1137-1141 (1999) (Pubitemid 29473206)
103. Jeschke M. G., G. Richter, F. Hofstadter, D. N. Herndon, J. R. Perez-Polo and K. W. Jauch: Non-viral liposomal keratinocyte growth factor (KGF) cDNA gene transfer improves dermal and epidermal regeneration through stimulation of epithelial and mesenchymal factors. Gene Ther 9, 1065-1074 (2002)
104. Jacobsen F, T. Hirsch, D. Mittler, M. Schulte, M. Lehnhardt, D. Druecke, H. H. Homann, H. U. Steinau and L. Steinstraesser: Polybrene improves transfection efficacy of recombinant replication-deficient adenovirus in cutaneous cells and burned skin. J Gene Med 8, 138-146 (2006) (Pubitemid 43250694)
105. Lee, S. G., S. J Yoon, C. D. Kim, K. Kim, D. S. Lim, Y. L. Yeom, M. W. Sung, D. S. Heo and N. K. Kim: Enhancement of adenoviral transduction with polycationic liposomes in vivo. Cancer Gene Ther 7, 1329-1335 (2000)
106. Chillon M, J. H. Lee, A. Fasbender and M. J. Welsh: Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther 5, 995-1002 (1998) (Pubitemid 28371917)
107. Yotnda P, D. H. Chen, W. Chiu, P. A. Piedra, A. Davis, N. S. Templeton and M. K. Brenner: Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses. Mol Ther 5, 233-241 (2002) (Pubitemid 34211218)
108. Zhang S, Y. Xu, B. Wang, W. Qiao, D. Liu and Z. Li: Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release 100, 165-180 (2004) (Pubitemid 39491269)
109. Jeschke M. G, G. Richter, D. N. Herndon, E. K. Geissler, M. Hartl, F. Hofstatter, K. W. Jauch and J. R. Perez-Polo: Therapeutic success and efficacy of nonviral liposomal cDNA gene transfer to the skin in vivo is dose dependent. Gene Ther 8, 1777-1784 (2001) (Pubitemid 34100578)
110. Jeschke M. G., D. N. Herndon, W. Baer, R. E. Barrow and K. W. Jauch: Possibilities of non-viral gene transfer to improve cutaneous wound healing. Curr Gene Ther 1, 267-278 (2001)
111. Tao Z, D. Herndon, H. Hawkins, T. Wood and J. R. Perez-Polo: Insulin-like growth factor-I cDNA gene transfer in vitro and in vivo. Biochem Genet 38, 41-55 (2000) (Pubitemid 30345815)
112. Vogel J. C: Nonviral skin gene therapy. Hum Gene Ther 11, 2253-2259 (2000)
113. Medina-Kauwe L. K, J. Xie, and S. Hamm-Alvarez: Intracellular trafficking of nonviral vectors. Gene Ther 12, 1734-1751
114. Felgner, P. L (1996) Improvements in cationic liposomes for in vivo gene transfer. Hum Gene Ther 7, 1791-1793 (2005)
115. Saeki Y, N. Matsumoto, Y. Nakano, M. Mori, K. Awai, and Y. Kaneda: Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 8, 2133-2141 (1997) (Pubitemid 28072583)
116. Benn S. I, J. S. Whitsitt, K. N. Broadley, L. B. Nanney, D. Perkins, L. He, M. Patel, J. R. Morgan, W. F. Swain and J. M. Davidson: Particle-mediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin. J Clin Invest 98, 2894-2902 (1996) (Pubitemid 26427419)
117. Williams R. S, S. A. Johnston, M. Riedy, M. J. DeVit, S. G. McElligott and J. C. Sanford: Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci U S A 88, 2726-2730 (1991) (Pubitemid 21916491)
118. Andree C, W. F. Swain, C. P. Page, M. D. Macklin, J. Slama, D. Hatzis and E. Eriksson: In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proceedings of the National Academy of Sciences of the United States of America 91, 12188-12192 (1994) (Pubitemid 24368630)
119. Eriksson E, F. Yao, T. Svensjo, T. Winkler, J. Slama, M. D. Macklin, C. Andree, M. McGregor, V. Hinshaw and W. Swain, In vivo gene transfer to skin and wound by microseeding. J Surg Res 78, 85-91 (1998) (Pubitemid 28419216)
120. Somiari S, J. Glasspool-Malone, J. J. Drabick, R. A. Gilbert, R. Heller, M. J. Jaroszeski and R. W. Malone: Theory and in vivo application of electroporative gene delivery. Mol Ther 2, 178-187 (2000)
121. Zhang L, E. Nolan, S. Kreitschitz and D. P. Rabussay: Enhanced delivery of naked DNA to the skin by noninvasive in vivo electroporation. Biochim Biophys Acta 1572, 1-9 (2002) (Pubitemid 35229983)
122. Budker V, T. Budker, G. Zhang, V. Subbotin, A. Loomis and J. A. Wolff: Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2, 76-88 (2000)
123. Glasspool-Malone J, S. Somiari, J. J. Drabick and R. W. Malone:. Efficient nonviral cutaneous transfection. Mol Ther 2, 140-146 (2000)
124. Byrnes C. K, R. W. Malone, N. Akhter, P. H. Nass, A. Wetterwald, M. G. Cecchini, M. D. Duncan and J. W. Harmon: Electroporation enhances transfection efficiency in murine cutaneous wounds. Wound Repair Regen 12, 397-403 (2004) (Pubitemid 39007039)
125. Barquinero J, H. Eixarch and M. Perez-Melgosa: Retroviral vectors: new applications for an old tool. Gene Ther 11 Suppl 1, S3-9 (2004) (Pubitemid 39359441)
126. Clackson T: Regulated gene expression systems. Gene Ther 7, 120-125 (2000) (Pubitemid 30088958)
127. No D, T. P. Yao and R. M. Evans: Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci U S A 93, 3346-3351 (1996) (Pubitemid 26125622)
128. Wang Y, B. W. O'Malley Jr., S. Y. Tsai, and B. W. O'Malley: A regulatory system for use in gene transfer. Proc Natl Acad Sci U S A 91, 8180-8184 (1994) (Pubitemid 24253910)
129. Gossen M, S. Freundlieb, G. Bender, G. Muller, W. Hillen and H. Bujard: Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769 (1995)
130. Herrlinger U, P. A. Pechan, A. H. Jacobs, C. Woiciechowski, N. G. Rainov, C. Fraefel, W. Paulus and S. A. Reeves: HSV-1 infected cell proteins influence tetracycline-regulated transgene expression. J Gene Med 2, 379-389 (2000)
131. Yao F and E. Eriksson: A novel tetracycline-inducible viral replication switch. Human Gene Therapy 10, 419-427 (1999) (Pubitemid 29097320)
132. Baron U, M. Gossen and H. Bujard: Tetracyclinecontrolled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 25, 2723-2729 (1997) (Pubitemid 27299784)
133. Shockett P, M. Difilippantonio, N. Hellman and G. D. Schatz: A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc Natl Acad Sci U S A 92, 6522-6526 (1995)
134. Kenny P. A, T. Enver and A. Ashworth: Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell line. BMC Mol Biol 3, 13 (2002)
135. Amarzguioui M, J. J. Rossi and D. Kim: Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett 579, 5974-5981 (2005) (Pubitemid 41484142)
136. Bridge A. J, S. Pebernard, A. Ducraux, A. L. Nicoulaz and R. Iggo, R: Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 34, 263-264 (2003) (Pubitemid 36792856)
137. Morris K. V: siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code. Cell Mol Life Sci 62, 3057-3066 (2005) (Pubitemid 43004754)
138. Schwarz K. W, M. T. Murray, R. Sylora, R. L. Sohn and S. A. Dulchavsky: Augmentation of wound healing with translation initiation factor eIF4E mRNA. J Surg Res 103, 175-182 (2002) (Pubitemid 34948499)
139. Jazag A, F. Kanai, H. Ijichi, K. Tateishi, T. Ikenoue, Y. Tanaka, M. Ohta, J. Imamura, B. Guleng, Y. Asaoka, T. Kawabe, M. Miyagishi, K. Taira and M. Omata: Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components. Nucleic Acids Res 33, e131 (2005)
140. Wang J. F, M. E. Olson, L. Ma, D. R. Brigstock and D. A. Hart: Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-beta 1-stimulated porcine skin fibroblasts. Wound Repair Regen 12, 205-216 (2004) (Pubitemid 38520687)
141. Baumgartner I, A. Pieczek, O. Manor, R. Blair, M. Kearney, K. Walsh and J. M. Isner: Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97, 1114-1123 (1998) (Pubitemid 28152883)
142. Kim H. J, S. Y. Jang, J. L. Park, J. Byun, D. L. Kim, Y. S. Do, J. M. Kim, S. Kim, B. M. Kim, W. B. Kim and D. K. Kim: Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease. Exp Mol Med 36, 336-344 (2004) (Pubitemid 39279529)
143. Morishita R, S. Nakamura, S. Hayashi, Y. Taniyama, A. Moriguchi, T. Nagano, M. Taiji, H. Noguchi, S. Takeshita, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara: Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy. Hypertension 33, 1379-1384 (1999) (Pubitemid 29282658)
144. Hayashi, S, R. Morishita, S. Nakamura, K. Yamamoto, A. Moriguchi, T. Nagano, M. Taiji, H. Noguchi, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara: Potential Role of Hepatocyte Growth Factor, a Novel Angiogenic Growth Factor, in Peripheral Arterial Disease: Downregulation of HGF in Response to Hypoxia in Vascular Cells. Circulation 100, 301II-308 (1999)
145. Morishita R, M. Aoki, N. Hashiya, H. Makino, K. Yamasaki, J. Azuma, Y. Sawa, H. Matsuda, Y. Kaneda and T. Ogihara: Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease. Hypertension 44, 203-209 (2004) (Pubitemid 39014240)